Co-Authors
This is a "connection" page, showing publications co-authored by Jingxian Zhao and Zhaoyong Zhang.
Connection Strength
0.923
-
Potent prophylactic and therapeutic efficacy of recombinant human ACE2-Fc against SARS-CoV-2 infection in vivo. Cell Discov. 2021 Aug 12; 7(1):65.
Score: 0.240
-
Narrative review of the novel coronavirus SARS-CoV-2: update on genomic characteristics, transmissions and animal model. J Thorac Dis. 2020 Dec; 12(12):7454-7466.
Score: 0.229
-
Multi-platform omics analysis reveals molecular signature for COVID-19 pathogenesis, prognosis and drug target discovery. Signal Transduct Target Ther. 2021 04 15; 6(1):155.
Score: 0.059
-
Mapping and role of T cell response in SARS-CoV-2-infected mice. J Exp Med. 2021 04 05; 218(4).
Score: 0.059
-
Intra-host variation and evolutionary dynamics of SARS-CoV-2 populations in COVID-19 patients. Genome Med. 2021 02 22; 13(1):30.
Score: 0.058
-
Population Bottlenecks and Intra-host Evolution During Human-to-Human Transmission of SARS-CoV-2. Front Med (Lausanne). 2021; 8:585358.
Score: 0.058
-
Kinetics of viral load and antibody response in relation to COVID-19 severity. J Clin Invest. 2020 10 01; 130(10):5235-5244.
Score: 0.057
-
Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment. Cell. 2020 08 06; 182(3):734-743.e5.
Score: 0.055
-
Complete Genome Sequences of Five Human Coronavirus NL63 Strains Causing Respiratory Illness in Hospitalized Children in China. Microbiol Resour Announc. 2020 Feb 20; 9(8).
Score: 0.054
-
Discovery of a subgenotype of human coronavirus NL63 associated with severe lower respiratory tract infection in China, 2018. Emerg Microbes Infect. 2020; 9(1):246-255.
Score: 0.054